Die Berenberg-Einschaetzung vom 18.09.2026 setzt auf geschaeftliche Entwicklung und Pipeline-Momentum. Im selben Datenbild ...
GSK slides 1.82% today to GBX1865.50 despite ongoing progress in oncology and vaccines, with volatility remaining elevated.
The latest installment in BioPharma Dive’s new visualization-focused series features a stock sell-off that confused Wall ...
On 8, 2026, CNBC reported that AstraZeneca PLC (NYSE:AZN) released full results from two successful late-stage trials of tozorakimab, an experimental drug for chronic obstructive pulmonary ...
Comstock Capital Value Fund reports quarterly portfolio activity and performance results. Read the full analysis for more details.
Independent Newspaper Nigeria on MSN
The multinationals betting on Nigeria
Nigeria’s corporate exodus story is by now a familiar one, with the ride-hailing app Uber’s September 2nd exit, after twelve years in the market, being the latest. In recent times, hypermarket giant ...
All deal values reflect company disclosures. Where parties have not disclosed terms, they are reported as undisclosed. No ...
GSK will acquire a Chimagen trispecific T cell engager for multiple myeloma in a deal worth up to $750M. Here's what it means ...
GSK plc is returning to China for another oncology asset, agreeing to acquire global rights to a preclinical trispecific T-cell engager from Chimagen Biosciences in a deal worth up to $750 million.
Alkermes plc (Nasdaq: ALKS) today announced the appointment of a new independent director, Anne C. Whitaker, to the company’s ...
GSK to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from China's Chimagen Biosciences for $750 ...
GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results